NORTH SHORE HEMATOLOGY-ONCOLOGY ASSOCIATES, P.C

Chief Executive Officer

Name	Role	Address
JEFFREY L VACIRCA, M.D.	Chief Executive Officer	1 RESEARCH ROAD, RIDGE, NY, United States, 11961

DOS Process Agent

Name	Role	Address
THE CORPORATION	DOS Process Agent	c/o 507 Plum Street, STE 310, SYRACUSE, NY, United States, 13204

U.S. Small Business Administration Profile

Phone Number:

631-675-5800

E-mail Address:

rmorgan@nycancer.com

Contact Person:

RUTH MORGAN

User ID:

P2908747

Unique Entity ID

Unique Entity ID:

FPDSK3EQCU14

CAGE Code:

9DH86

UEI Expiration Date:

2026-02-17

Business Information

Activation Date:

2025-02-19

Initial Registration Date:

2022-10-03

Commercial and government entity program

CAGE number:

9DH86

Status:

Active

Type:

Non-Manufacturer

CAGE Update Date:

2025-02-19

CAGE Expiration:

2030-02-19

SAM Expiration:

2026-02-17

Contact Information

POC:

RUTH MORGAN

National Provider Identifier

NPI Number:

1083427983

Certification Date:

2025-01-27

Link:

View on NPI website

Authorized Person:

Name:

PATRICIA DANDRAIA

Role:

SENIOR DIRECTOR

Phone:

6317513000

Taxonomy:

Selected Taxonomy:

2085U0001X - Diagnostic Ultrasound Physician

Is Primary:

No

Selected Taxonomy:

208800000X - Urology Physician

Is Primary:

Yes

Contacts:

Phone:

+1 631-751-3000

Phone:

+1 718-696-0186

Legal Entity Identifier

LEI Number:

254900AMQUPT343F0I64

Registration Details:

Initial Registration Date:

2020-02-12

Next Renewal Date:

2026-02-12

Registration Status:

ISSUED

Validation Source:

FULLY_CORROBORATED

Form 5500 Series

Employer Identification Number (EIN):

112419534

Plan Year:

2022

Number Of Participants:

0

Sponsors Telephone Number:

6317513000

File:

View File

History

Start date	End date	Type	Value
2024-12-23	2025-06-12	Shares	Share type: NO PAR VALUE, Number of shares: 1000, Par value: 0
2024-08-26	2024-12-23	Shares	Share type: NO PAR VALUE, Number of shares: 1000, Par value: 0
2024-07-24	2024-08-26	Shares	Share type: NO PAR VALUE, Number of shares: 1000, Par value: 0
2024-07-24	2024-07-24	Shares	Share type: NO PAR VALUE, Number of shares: 1000, Par value: 0
2023-06-26	2024-07-24	Shares	Share type: NO PAR VALUE, Number of shares: 1000, Par value: 0

Filings

Filing Number	Date Filed	Type	Effective Date
230428003449	2023-04-28	BIENNIAL STATEMENT	2023-04-01
220607000261	2022-06-07	AMENDMENT TO BIENNIAL STATEMENT	2022-06-07
211222002008	2021-12-22	BIENNIAL STATEMENT	2021-12-22
190411060379	2019-04-11	BIENNIAL STATEMENT	2019-04-01
170717000314	2017-07-17	CERTIFICATE OF AMENDMENT	2017-07-17

Trademarks Section

Serial Number:

87688894

Mark:

NEW YORK CANCER & BLOOD SPECIALISTS

Status:

SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

Mark Type:

SERVICE MARK

Application Filing Date:

2017-11-17

Mark Drawing Type:

Illustration: Drawing or design which also includes word(s)/letter(s)/number(s)

Mark Literal Elements:

NEW YORK CANCER & BLOOD SPECIALISTS

USPTO Link:

View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:

Medical services; healthcare; healthcare services, namely, diagnosis and treatment of cancer; hematology and oncology consulting services; healthcare and medical services, namely, chemotherapy and radiation therapy, diagnostic imaging, circulating tumor cell (ctc) testing, prostate vaccination thera...

International Classes:

044 - Primary Class

Class Status:

Active

For:

Medical research, namely, conducting clinical trials for others

International Classes:

042 - Primary Class

Class Status:

Active

Serial Number:

87688844

Status:

SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

Mark Type:

SERVICE MARK

Application Filing Date:

2017-11-17

Mark Drawing Type:

Illustration: Drawing or design without any word(s)/letter(s)/number(s)

USPTO Link:

View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:

Medical services; healthcare; healthcare services, namely, diagnosis and treatment of cancer; hematology and oncology consulting services; healthcare and medical services, namely, chemotherapy and radiation therapy, diagnostic imaging, circulating tumor cell (ctc) testing, prostate vaccination thera...

International Classes:

044 - Primary Class

Class Status:

Active

For:

Medical research, namely, conducting clinical trials for others

International Classes:

042 - Primary Class

Class Status:

Active

Serial Number:

87260432

Mark:

CONQUERING CANCER TOGETHER

Status:

SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

Mark Type:

SERVICE MARK

Application Filing Date:

2016-12-07

Mark Drawing Type:

Standard character mark

Mark Literal Elements:

CONQUERING CANCER TOGETHER

USPTO Link:

View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:

Medical services; healthcare; healthcare services, namely, diagnosis and treatment of cancer; hematology and oncology consulting services; healthcare and medical services, namely, chemotherapy and radiation therapy, diagnostic imaging, circulating tumor cell (ctc) testing, prostate vaccination thera...

International Classes:

044 - Primary Class

Class Status:

Active

For:

Medical research, namely, conducting clinical trials for others

International Classes:

042 - Primary Class

Class Status:

Active

Serial Number:

85778176

Mark:

CONQUERING CANCER...CLOSE TO HOME

Status:

REGISTERED AND RENEWED

Mark Type:

SERVICE MARK

Application Filing Date:

2012-11-13

Mark Drawing Type:

Standard character mark

Mark Literal Elements:

CONQUERING CANCER...CLOSE TO HOME

USPTO Link:

View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:

Medical services; healthcare; healthcare services, namely, diagnosis and treatment of cancer; hematology and oncology consulting services; healthcare and medical services, namely, chemotherapy and radiation therapy, diagnostic imaging, circulating tumor cell (ctc) testing, prostate vaccination thera...

International Classes:

044 - Primary Class

Class Status:

Active

For:

Medical research, namely, conducting clinical trials for others

International Classes:

042 - Primary Class

Class Status:

Active

Name:	NORTH SHORE HEMATOLOGY-ONCOLOGY ASSOCIATES, P.C.
Jurisdiction:	New York
Legal type:	DOMESTIC PROFESSIONAL SERVICE CORPORATION
Status:	Active
Date of registration:	01 Apr 1977 (48 years ago)
Entity Number:	429488
ZIP code:	13204
County:	Suffolk
Place of Formation:	New York
Address:	c/o 507 Plum Street, STE 310, SYRACUSE, NY, United States, 13204
Principal Address:	1 Research road, RIDGE, NY, United States, 11961

NORTH SHORE HEMATOLOGY-ONCOLOGY ASSOCIATES, P.C.

Is this your business?

Company Details

Chief Executive Officer

DOS Process Agent

U.S. Small Business Administration Profile

Unique Entity ID

Business Information

Commercial and government entity program

Contact Information

National Provider Identifier

Authorized Person:

Taxonomy:

Contacts:

Legal Entity Identifier

Registration Details:

Form 5500 Series

History

Filings

Trademarks Section

Goods And Services

Goods And Services

Goods And Services

Goods And Services

Reviews Leave a review

NORTH SHORE HEMATOLOGY-ONCOLOGY ASSOCIATES, P.C.

Is this your business?

Company Details

Chief Executive Officer

DOS Process Agent

U.S. Small Business Administration Profile

Unique Entity ID

Business Information

Commercial and government entity program

Contact Information

National Provider Identifier

Authorized Person:

Taxonomy:

Contacts:

Legal Entity Identifier

Registration Details:

Form 5500 Series

History

Filings

Trademarks Section

Goods And Services

Goods And Services

Goods And Services

Goods And Services

Reviews Leave a review

Related by officers

Related by address